PRESS RELEASES

<< Back
Mar 4, 2019

Chimerix to Present at Cowen and Company 39th Annual Health Care Conference

DURHAM, N.C., March 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that Timothy Trost, Chief Financial Officer of Chimerix, will present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 at 3:30 p.m. ET at the Boston Marriott Copley Place.

A live audio webcast of the presentation will be available on the Investor Relations section of Chimerix’s website at ir.chimerix.com, where it will be archived for approximately 90 days.

About Chimerix
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Brincidofovir (BCV, CMX001) uses Chimerix's proprietary lipid conjugate technology. For further information, please visit Chimerix's website, www.chimerix.com.

CONTACT:
Investor Relations:
Michelle LaSpaluto
(919) 972-7115
ir@chimerix.com
or
Will O’Connor
Stern Investor Relations
Will@sternir.com 
212-362-1200

Media:
Becky Vonsiatsky
W2O Group
bvonsiatsky@w2ogroup.com 
413-478-2003 

Chimerix logo

Source: Chimerix, Inc.